RxDoctor Payments Data

Jonelle Ensor, PA

Physician Assistant · Clearfield, PANPI 1487964219

Payments from drug & device makers

$454in general payments, 2019–2025

Across 28 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$142
  • GSK$87
  • Pfizer$86
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • Xeris Pharmaceuticals, Inc.$27
  • Novo Nordisk$25
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$454100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$454 in reported general payments places this provider in the 65th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$68,301
Medicare patients
248
Services billed
1,155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban134$169,517
JardianceEmpagliflozin81$86,457
OzempicSemaglutide36$46,886
XareltoRivaroxaban33$41,094
TrulicityDulaglutide21$32,477
FarxigaDapagliflozin Propanediol12$19,379
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$17,676
EntrestoSacubitril/Valsartan16$16,344
Tresiba Flextouch U-100Insulin Degludec23$14,417
MyrbetriqMirabegron13$10,253
Potassium Chloride228$7,481
Fluticasone-SalmeterolFluticasone Propion/Salmeterol32$6,955
Breo ElliptaFluticasone/Vilanterol12$6,528
Atorvastatin Calcium371$6,102
Janumet XrSitagliptin Phos/Metformin Hcl11$5,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$86$169,517134 claims
Novo NordiskOzempic$25$46,88636 claims
GSKTrelegy Ellipta, Breo Ellipta$87$24,20432 claims
MerckJanumet Xr$12$5,03911 claims
AbbVieSynthroid$142$1,95540 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Clearfield

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →